{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:40:00Z","timestamp":1791297600605,"version":"4.1.0"},"reference-count":230,"publisher":"Frontiers Media SA","funder":[{"name":"Norman & Bettina Roberts Foundation Inc."},{"DOI":"10.13039\/100001445","name":"Alex\u2019s Lemonade Stand Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001445","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008258","name":"Hyundai Hope On Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2015.00190","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T06:20:43Z","timestamp":1442989243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas"],"prefix":"10.3389","volume":"5","author":[{"given":"Michael D.","family":"Deel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny J.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E. S.","family":"Crose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne M.","family":"Linardic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2045-3329-2-14","article-title":"The epidemiology of sarcoma","volume":"2","author":"Burningham","year":"2012","journal-title":"Clin Sarcoma Res"},{"issue":"6","key":"B2","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/pbc.24429","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: bone tumors","volume":"60","author":"Gorlick","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"B3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/pbc.24435","article-title":"Children\u2019s Oncology Group\u2019s 2013 blueprint for research: soft tissue sarcomas","volume":"60","author":"Hawkins","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"B4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0092-8674(03)00549-X","article-title":"Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts","volume":"114","author":"Wu","year":"2003","journal-title":"Cell"},{"issue":"4","key":"B5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0092-8674(03)00557-9","article-title":"The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis","volume":"114","author":"Harvey","year":"2003","journal-title":"Cell"},{"issue":"3","key":"B6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2005.06.007","article-title":"The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP","volume":"122","author":"Huang","year":"2005","journal-title":"Cell"},{"issue":"4","key":"B7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0092-8674(02)00824-3","article-title":"Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines","volume":"110","author":"Tapon","year":"2002","journal-title":"Cell"},{"issue":"4","key":"B8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev Cell"},{"issue":"21","key":"B9","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Gene Dev"},{"issue":"6","key":"B10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","article-title":"Elucidation of a universal size-control mechanism in Drosophila and mammals","volume":"130","author":"Dong","year":"2007","journal-title":"Cell"},{"issue":"10","key":"B11","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ncb1051","article-title":"The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila","volume":"5","author":"Pantalacci","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"10","key":"B12","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ncb1050","article-title":"Hippo promotes proliferation arrest and apoptosis in the Salvador\/Warts pathway","volume":"5","author":"Udan","year":"2003","journal-title":"Nat Cell Biol"},{"issue":"5","key":"B13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1101\/gad.9.5.534","article-title":"The Drosophila tumor-\u00adsuppressor gene warts encodes a homolog of human myotonic-\u00addystrophy kinase and is required for the control of cell-shape and proliferation","volume":"9","author":"Justice","year":"1995","journal-title":"Gene Dev"},{"issue":"4","key":"B14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1242\/dev.121.4.1053","article-title":"Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase","volume":"121","author":"Xu","year":"1995","journal-title":"Development"},{"issue":"9","key":"B15","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.cellsig.2011.04.007","article-title":"MOB control: reviewing a conserved family of kinase regulators","volume":"23","author":"Hergovich","year":"2011","journal-title":"Cell Signal"},{"issue":"7","key":"B16","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.semcdb.2012.05.004","article-title":"The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway","volume":"23","author":"Hong","year":"2012","journal-title":"Semin Cell Dev Biol"},{"issue":"14","key":"B17","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev"},{"issue":"3","key":"B18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1158\/0008-5472.CAN-08-2997","article-title":"Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein","volume":"69","author":"Zhao","year":"2009","journal-title":"Cancer Res"},{"issue":"20","key":"B19","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1074\/jbc.M900843200","article-title":"TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-\u00admesenchymal transition","volume":"284","author":"Zhang","year":"2009","journal-title":"J Biol Chem"},{"issue":"21","key":"B20","doi-asserted-by":"publisher","first-page":"14347","DOI":"10.1074\/jbc.M901568200","article-title":"TEADs mediate nuclear retention of TAZ to promote oncogenic transformation","volume":"284","author":"Chan","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbrc.2015.01.077","article-title":"YAP\/TAZ enhance mammalian embryonic neural stem cell characteristics in a Tead-dependent manner","volume":"458","author":"Han","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"B22","doi-asserted-by":"publisher","first-page":"R574","DOI":"10.1016\/j.cub.2010.05.023","article-title":"Upstream regulation of the Hippo size control pathway","volume":"20","author":"Grusche","year":"2010","journal-title":"Curr Biol"},{"issue":"1","key":"B23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1074\/mcp.M113.030049","article-title":"Defining the \u00adprotein\u2013protein interaction network of the human Hippo pathway","volume":"13","author":"Wang","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"6159","key":"B24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1126\/science.1243971","article-title":"The Hippo signaling pathway interactome","volume":"342","author":"Kwon","year":"2013","journal-title":"Science"},{"issue":"302","key":"B25","doi-asserted-by":"publisher","first-page":"rs15","DOI":"10.1126\/scisignal.2004712","article-title":"Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions","volume":"6","author":"Couzens","year":"2013","journal-title":"Sci Signal"},{"issue":"7","key":"B26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.semcdb.2012.06.001","article-title":"Regulation of the Hippo pathway by cell architecture and mechanical signals","volume":"23","author":"Schroeder","year":"2012","journal-title":"Semin Cell Dev Biol"},{"issue":"49","key":"B27","doi-asserted-by":"publisher","first-page":"E1312","DOI":"10.1073\/pnas.1110428108","article-title":"Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance","volume":"108","author":"Zhou","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"291","key":"B28","doi-asserted-by":"publisher","first-page":"ra77","DOI":"10.1126\/scisignal.2004060","article-title":"The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis","volume":"6","author":"Yi","year":"2013","journal-title":"Sci Signal"},{"issue":"4","key":"B29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","article-title":"Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"issue":"1","key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ncb1339","article-title":"The tumour-suppressor genes NF2\/Merlin and expanded act through Hippo signalling to regulate cell proliferation and apoptosis","volume":"8","author":"Hamaratoglu","year":"2006","journal-title":"Nat Cell Biol"},{"issue":"6","key":"B31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2013.08.025","article-title":"Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin\/NF2","volume":"154","author":"Yin","year":"2013","journal-title":"Cell"},{"issue":"8","key":"B32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev"},{"issue":"21","key":"B33","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.cub.2006.09.004","article-title":"The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway","volume":"16","author":"Silva","year":"2006","journal-title":"Curr Biol"},{"issue":"10","key":"B34","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1242\/dev.064204","article-title":"FatJ acts via the Hippo mediator Yap1 to restrict the size of neural progenitor cell pools","volume":"138","author":"Van Hateren","year":"2011","journal-title":"Development"},{"key":"B35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/S0076-6879(05)07025-4","article-title":"Nore1 and RASSF1 regulation of cell proliferation and of the MST1\/2 kinases","volume":"407","author":"Avruch","year":"2006","journal-title":"Methods Enzymol"},{"issue":"24","key":"B36","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1016\/j.cub.2006.10.060","article-title":"The Drosophila RASSF homolog antagonizes the hippo pathway","volume":"16","author":"Polesello","year":"2006","journal-title":"Curr Biol"},{"issue":"2","key":"B37","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.devcel.2009.12.012","article-title":"Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded","volume":"18","author":"Yu","year":"2010","journal-title":"Dev Cell"},{"issue":"2","key":"B38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.devcel.2009.12.013","article-title":"The WW domain protein Kibra acts upstream of Hippo in Drosophila","volume":"18","author":"Baumgartner","year":"2010","journal-title":"Dev Cell"},{"issue":"2","key":"B39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.devcel.2009.12.011","article-title":"Kibra is a regulator of the Salvador\/Warts\/Hippo signaling network","volume":"18","author":"Genevet","year":"2010","journal-title":"Dev Cell"},{"issue":"5","key":"B40","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.devcel.2011.09.012","article-title":"The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway","volume":"21","author":"Poon","year":"2011","journal-title":"Dev Cell"},{"issue":"1","key":"B41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/ncb2884","article-title":"A genetic screen identifies an LKB1\u2013MARK signalling axis controlling the Hippo\u2013YAP pathway","volume":"16","author":"Mohseni","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"23","key":"B42","doi-asserted-by":"publisher","first-page":"R899","DOI":"10.1016\/j.cub.2003.11.007","article-title":"A novel interaction motif, SARAH, connects three classes of tumor suppressor","volume":"13","author":"Scheel","year":"2003","journal-title":"Curr Biol"},{"issue":"14","key":"B43","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/onc.2012.196","article-title":"KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals","volume":"32","author":"Moleirinho","year":"2013","journal-title":"Oncogene"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ccr.2008.02.011","article-title":"The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals","volume":"13","author":"Zeng","year":"2008","journal-title":"Cancer Cell"},{"issue":"9","key":"B45","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1101\/gad.1054603","article-title":"NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions","volume":"17","author":"Lallemand","year":"2003","journal-title":"Gene Dev"},{"issue":"5","key":"B46","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.devcel.2010.10.008","article-title":"The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex","volume":"19","author":"Gladden","year":"2010","journal-title":"Dev Cell"},{"issue":"11","key":"B47","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/carcin\/bgn200","article-title":"YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation","volume":"29","author":"Yokoyama","year":"2008","journal-title":"Carcinogenesis"},{"issue":"11","key":"B48","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1593\/neo.08642","article-title":"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP","volume":"10","author":"Striedinger","year":"2008","journal-title":"Neoplasia"},{"issue":"12","key":"B49","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Gene Dev"},{"issue":"12","key":"B50","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gad.262816.115","article-title":"A YAP\/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis","volume":"29","author":"Moroishi","year":"2015","journal-title":"Genes Dev"},{"issue":"14","key":"B51","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2011.363","article-title":"Integrating developmental signals: a Hippo in the (path)way","volume":"31","author":"Mauviel","year":"2012","journal-title":"Oncogene"},{"issue":"10","key":"B52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jgg.2011.09.009","article-title":"Hippo signaling: a hub of growth control, tumor suppression and pluripotency maintenance","volume":"38","author":"Yin","year":"2011","journal-title":"J Genet Genomics"},{"issue":"7","key":"B53","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.semcdb.2012.04.006","article-title":"Integration of intercellular signaling through the Hippo pathway","volume":"23","author":"Irvine","year":"2012","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2007.10.006","article-title":"A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis","volume":"2","author":"Brack","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"39","key":"B55","doi-asserted-by":"publisher","first-page":"33132","DOI":"10.1074\/jbc.M500608200","article-title":"Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression","volume":"280","author":"Gaur","year":"2005","journal-title":"J Biol Chem"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.429","article-title":"NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma","author":"Zhao","year":"2015","journal-title":"Oncogene"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1797","article-title":"Secreted frizzled related protein 3 (SFRP3) is required for tumorigenesis of PAX3-FOXO1-positive alveolar rhabdomyosarcoma","author":"Kephart","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"7","key":"B58","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","article-title":"beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis","volume":"151","author":"Rosenbluh","year":"2012","journal-title":"Cell"},{"issue":"6028","key":"B59","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","article-title":"Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size","volume":"332","author":"Heallen","year":"2011","journal-title":"Science"},{"issue":"4","key":"B60","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","article-title":"Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways","volume":"139","author":"Alarcon","year":"2009","journal-title":"Cell"},{"issue":"6","key":"B61","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.devcel.2010.11.012","article-title":"The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway","volume":"19","author":"Varelas","year":"2010","journal-title":"Dev Cell"},{"issue":"4","key":"B62","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.devcel.2010.03.007","article-title":"The hippo pathway regulates Wnt\/beta-catenin signaling","volume":"18","author":"Varelas","year":"2010","journal-title":"Dev Cell"},{"issue":"5737","key":"B63","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1110955","article-title":"TAZ, a transcriptional modulator of mesenchymal stem cell differentiation","volume":"309","author":"Hong","year":"2005","journal-title":"Science"},{"issue":"3","key":"B64","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ccr.2014.07.023","article-title":"Notch activation as a driver of osteogenic sarcoma","volume":"26","author":"Tao","year":"2014","journal-title":"Cancer Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1741-7015-10-141","article-title":"Notch signaling in pediatric soft tissue sarcomas","volume":"10","author":"Rota","year":"2012","journal-title":"BMC Med"},{"issue":"23","key":"B66","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1158\/1078-0432.CCR-11-1004","article-title":"Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis","volume":"17","author":"Belyea","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"23","key":"B67","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","article-title":"YAP1 increases organ size and expands undifferentiated progenitor cells","volume":"17","author":"Camargo","year":"2007","journal-title":"Curr Biol"},{"issue":"6","key":"B68","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/cdd.2014.8","article-title":"Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation","volume":"21","author":"Byun","year":"2014","journal-title":"Cell Death Differ"},{"issue":"1","key":"B69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","article-title":"YAP\/TAZ incorporation in the beta-catenin destruction complex orchestrates the Wnt response","volume":"158","author":"Azzolin","year":"2014","journal-title":"Cell"},{"issue":"7","key":"B70","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.cell.2012.11.027","article-title":"Role of TAZ as mediator of Wnt signaling","volume":"151","author":"Azzolin","year":"2012","journal-title":"Cell"},{"issue":"19","key":"B71","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.1074\/jbc.M113.529115","article-title":"The transcriptional regulators TAZ and YAP direct transforming growth factor beta-induced tumorigenic phenotypes in breast cancer cells","volume":"289","author":"Hiemer","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"B72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.stem.2013.12.009","article-title":"Hippo tips the TGF-beta scale in favor of pluripotency","volume":"14","author":"Mullen","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"7","key":"B73","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/ncb1748","article-title":"TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal","volume":"10","author":"Varelas","year":"2008","journal-title":"Nat Cell Biol"},{"issue":"11","key":"B74","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1101\/gad.1903310","article-title":"The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation","volume":"24","author":"Lian","year":"2010","journal-title":"Genes Dev"},{"issue":"Pt 14","key":"B75","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1242\/jcs.041806","article-title":"The Hippo pathway regulates apical-domain size independently of its growth-control function","volume":"122","author":"Genevet","year":"2009","journal-title":"J Cell Sci"},{"issue":"21","key":"B76","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.cub.2007.11.005","article-title":"Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch","volume":"17","author":"Polesello","year":"2007","journal-title":"Curr Biol"},{"issue":"3","key":"B77","doi-asserted-by":"publisher","first-page":"e1761","DOI":"10.1371\/journal.pone.0001761","article-title":"The hippo pathway promotes Notch signaling in regulation of cell differentiation, proliferation, and oocyte polarity","volume":"3","author":"Yu","year":"2008","journal-title":"PLoS One"},{"issue":"23","key":"B78","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1101\/gad.1824509","article-title":"YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation","volume":"23","author":"Fernandez","year":"2009","journal-title":"Genes Dev"},{"issue":"3","key":"B79","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1083\/jcb.201309141","article-title":"Coupling of Hedgehog and Hippo pathways promotes stem cell maintenance by stimulating proliferation","volume":"205","author":"Huang","year":"2014","journal-title":"J Cell Biol"},{"issue":"40","key":"B80","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1038\/onc.2013.433","article-title":"Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression","volume":"33","author":"Chan","year":"2014","journal-title":"Oncogene"},{"issue":"5","key":"B81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.devcel.2013.01.020","article-title":"Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins","volume":"24","author":"Reddy","year":"2013","journal-title":"Dev Cell"},{"issue":"5","key":"B82","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.18632\/oncotarget.3095","article-title":"Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"B83","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bone.2013.09.024","article-title":"FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression","volume":"58","author":"Byun","year":"2014","journal-title":"Bone"},{"key":"B84","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","article-title":"Novel insights into G protein and G protein-coupled receptor signaling in cancer","volume":"27","author":"O\u2019Hayre","year":"2014","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"B85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/abbs\/gmu108","article-title":"G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway","volume":"47","author":"Zhou","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"292","key":"B86","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2004324","article-title":"Ajuba family proteins link JNK to Hippo signaling","volume":"6","author":"Sun","year":"2013","journal-title":"Sci Signal"},{"issue":"1","key":"B87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ydbio.2010.11.036","article-title":"Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors","volume":"350","author":"Sun","year":"2011","journal-title":"Dev Biol"},{"issue":"355","key":"B88","doi-asserted-by":"publisher","first-page":"ra116","DOI":"10.1126\/scisignal.2005770","article-title":"Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration","volume":"7","author":"Haskins","year":"2014","journal-title":"Sci Signal"},{"issue":"12","key":"B89","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ncb2615","article-title":"YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29","volume":"14","author":"Tumaneng","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"4","key":"B90","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells1040886","article-title":"Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway","volume":"1","author":"Chiang","year":"2012","journal-title":"Cells"},{"issue":"1","key":"B91","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.celrep.2015.03.010","article-title":"mTORC2 regulates cardiac response to stress by inhibiting MST1","volume":"11","author":"Sciarretta","year":"2015","journal-title":"Cell Rep"},{"issue":"24","key":"B92","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1242\/dev.060483","article-title":"The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration","volume":"137","author":"Karpowicz","year":"2010","journal-title":"Development"},{"issue":"17","key":"B93","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cub.2010.07.041","article-title":"Warts and Yorkie mediate intestinal regeneration by influencing stem cell proliferation","volume":"20","author":"Staley","year":"2010","journal-title":"Curr Biol"},{"issue":"21","key":"B94","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.15252\/embj.201490014","article-title":"The RAS and YAP1 dance, who is leading?","volume":"33","author":"Corbo","year":"2014","journal-title":"EMBO J"},{"issue":"21","key":"B95","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.15252\/embj.201489385","article-title":"Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover","volume":"33","author":"Hong","year":"2014","journal-title":"EMBO J"},{"issue":"324","key":"B96","doi-asserted-by":"publisher","first-page":"ra42","DOI":"10.1126\/scisignal.2005049","article-title":"Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Sci Signal"},{"key":"B97","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1038\/ncomms7411","article-title":"Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells","volume":"6","author":"Basu-Roy","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"B98","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.celrep.2013.05.029","article-title":"SOX2 regulates YAP1 to maintain stemness and determine cell fate in the osteo-adipo lineage","volume":"3","author":"Seo","year":"2013","journal-title":"Cell Rep"},{"issue":"4","key":"B99","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.devcel.2013.04.011","article-title":"MT1-MMP-dependent control of skeletal stem cell commitment via a beta1-integrin\/YAP\/TAZ signaling axis","volume":"25","author":"Tang","year":"2013","journal-title":"Dev Cell"},{"issue":"4","key":"B100","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ncb2936","article-title":"Metabolic control of YAP and TAZ by the mevalonate pathway","volume":"16","author":"Sorrentino","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"1","key":"B101","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.1073\/pnas.1319190110","article-title":"Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"B102","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.15252\/embj.201490379","article-title":"Aerobic glycolysis tunes YAP\/TAZ transcriptional activity","volume":"34","author":"Enzo","year":"2015","journal-title":"EMBO J"},{"issue":"4","key":"B103","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/ncb3113","article-title":"AMPK modulates Hippo pathway activity to regulate energy homeostasis","volume":"17","author":"Wang","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"2","key":"B104","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.devcel.2013.05.025","article-title":"Control of the hippo pathway by Set7-dependent methylation of Yap","volume":"26","author":"Oudhoff","year":"2013","journal-title":"Dev Cell"},{"issue":"22","key":"B105","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1158\/0008-5472.CAN-13-2049","article-title":"CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation","volume":"73","author":"Yang","year":"2013","journal-title":"Cancer Res"},{"issue":"12","key":"B106","doi-asserted-by":"publisher","first-page":"a005066","DOI":"10.1101\/cshperspect.a005066","article-title":"Integrins and extracellular matrix in mechanotransduction","volume":"2","author":"Schwartz","year":"2010","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"4","key":"B107","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrm1890","article-title":"Local force and geometry sensing regulate cell functions","volume":"7","author":"Vogel","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"B108","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrm3416","article-title":"Transduction of mechanical and cytoskeletal cues by YAP and TAZ","volume":"13","author":"Halder","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5935","key":"B109","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1126\/science.1171643","article-title":"Growth factors, matrices, and forces combine and control stem cells","volume":"324","author":"Discher","year":"2009","journal-title":"Science"},{"issue":"1","key":"B110","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrm2597","article-title":"Mechanotransduction gone awry","volume":"10","author":"Jaalouk","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"B111","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ceb.2009.08.001","article-title":"Cytoskeletal control of growth and cell fate switching","volume":"21","author":"Mammoto","year":"2009","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"B112","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2014.05.035","article-title":"Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex","volume":"158","author":"Rauskolb","year":"2014","journal-title":"Cell"},{"issue":"7350","key":"B113","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"issue":"12","key":"B114","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1038\/emboj.2011.157","article-title":"Modulating F-actin organization induces organ growth by affecting the Hippo pathway","volume":"30","author":"Sansores-Garcia","year":"2011","journal-title":"EMBO J"},{"issue":"18","key":"B115","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1242\/dev.070987","article-title":"Hippo pathway regulation by cell morphology and stress fibers","volume":"138","author":"Wada","year":"2011","journal-title":"Development"},{"issue":"1","key":"B116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1101\/gad.173435.111","article-title":"Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis","volume":"26","author":"Zhao","year":"2012","journal-title":"Gene Dev"},{"issue":"4","key":"B117","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1152\/physrev.00005.2014","article-title":"The biology of YAP\/TAZ: hippo signaling and beyond","volume":"94","author":"Piccolo","year":"2014","journal-title":"Physiol Rev"},{"issue":"1","key":"B118","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1097\/BOR.0b013e32835b13cd","article-title":"Biomechanical regulation of mesenchymal cell function","volume":"25","author":"Tschumperlin","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"B119","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"issue":"4","key":"B120","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1534-5807(04)00075-9","article-title":"Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment","volume":"6","author":"McBeath","year":"2004","journal-title":"Dev Cell"},{"issue":"1","key":"B121","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2116","article-title":"Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation","volume":"9","author":"Kolf","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"B122","doi-asserted-by":"publisher","first-page":"642","DOI":"10.15252\/embr.201438638","article-title":"The Hippo signaling pathway in stem cell biology and cancer","volume":"15","author":"Mo","year":"2014","journal-title":"EMBO Rep"},{"issue":"10","key":"B123","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1002\/stem.1759","article-title":"The regulatory landscape of osteogenic differentiation","volume":"32","author":"Hakelien","year":"2014","journal-title":"Stem Cells"},{"issue":"9","key":"B124","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/emboj\/18.9.2551","article-title":"A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator","volume":"18","author":"Yagi","year":"1999","journal-title":"EMBO J"},{"issue":"3","key":"B125","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1128\/MCB.23.3.1004-1013.2003","article-title":"Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ","volume":"23","author":"Cui","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"2","key":"B126","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4161\/cc.5.2.2362","article-title":"TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation","volume":"5","author":"Hong","year":"2006","journal-title":"Cell Cycle"},{"issue":"2","key":"B127","doi-asserted-by":"publisher","first-page":"e56585","DOI":"10.1371\/journal.pone.0056585","article-title":"Osteoblast-targeted overexpression of TAZ increases bone mass in vivo","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"B128","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.emboj.7600073","article-title":"Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription","volume":"23","author":"Zaidi","year":"2004","journal-title":"EMBO J"},{"key":"B129","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1471-2407-10-298","article-title":"The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts","volume":"10","author":"Id Boufker","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"B130","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/emboj.2011.480","article-title":"Ablation of Rassf2 induces bone defects and subsequent haematopoietic anomalies in mice","volume":"31","author":"Song","year":"2012","journal-title":"EMBO J"},{"issue":"10","key":"B131","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.bcp.2009.07.001","article-title":"Augmentation of PPARgamma-TAZ interaction contributes to the anti-adipogenic activity of KR62980","volume":"78","author":"Jung","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"B132","doi-asserted-by":"publisher","first-page":"e30983","DOI":"10.1371\/journal.pone.0030983","article-title":"Mammalian ste20-like kinase and SAV1 promote 3T3-L1 adipocyte differentiation by activation of PPARgamma","volume":"7","author":"Park","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"B133","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1083\/jcb.200502101","article-title":"MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions","volume":"171","author":"Ishibashi","year":"2005","journal-title":"J Cell Biol"},{"issue":"3","key":"B134","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/bies.950170306","article-title":"The MyoD family of transcription factors and skeletal myogenesis","volume":"17","author":"Rudnicki","year":"1995","journal-title":"Bioessays"},{"issue":"7","key":"B135","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1128\/MCB.21.7.2404-2412.2001","article-title":"Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family","volume":"21","author":"Bergstrom","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.cellbio.14.1.167","article-title":"Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins","volume":"14","author":"Black","year":"1998","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"B137","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1074\/jbc.M114.589838","article-title":"MEF2 transcription factors regulate distinct gene programs in mammalian skeletal muscle differentiation","volume":"290","author":"Estrella","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"B138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccr.2014.05.029","article-title":"The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation","volume":"26","author":"Tremblay","year":"2014","journal-title":"Cancer Cell"},{"issue":"4","key":"B139","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbrc.2010.02.034","article-title":"Yap is a novel regulator of C2C12 myogenesis","volume":"393","author":"Watt","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 24","key":"B140","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.1242\/jcs.109546","article-title":"The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells","volume":"125","author":"Judson","year":"2012","journal-title":"J Cell Sci"},{"issue":"1","key":"B141","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/ATVBAHA.107.155788","article-title":"MCAT elements and the TEF-1 family of transcription factors in muscle development and disease","volume":"28","author":"Yoshida","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"B142","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1096\/fj.09-151324","article-title":"TAZ as a novel enhancer of MyoD-mediated myogenic differentiation","volume":"24","author":"Jeong","year":"2010","journal-title":"FASEB J"},{"issue":"17","key":"B143","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1111\/bph.12755","article-title":"Novel TAZ modulators enhance myogenic differentiation and muscle regeneration","volume":"171","author":"Park","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"17","key":"B144","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1073\/pnas.162172899","article-title":"Caspase 3 activity is required for skeletal muscle differentiation","volume":"99","author":"Fernando","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"B145","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.pcl.2014.09.012","article-title":"Sarcomas","volume":"62","author":"HaDuong","year":"2015","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"B146","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/jb\/mvr021","article-title":"Mammalian Hippo pathway: from development to cancer and beyond","volume":"149","author":"Bao","year":"2011","journal-title":"J Biochem"},{"issue":"8","key":"B147","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1101\/gad.12.8.1121","article-title":"Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors","volume":"12","author":"McClatchey","year":"1998","journal-title":"Gene Dev"},{"issue":"12","key":"B148","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1172\/JCI63735","article-title":"Cancer susceptibility and embryonic lethality in Mob1a\/1b double-mutant mice","volume":"122","author":"Nishio","year":"2012","journal-title":"J Clin Investig"},{"issue":"2","key":"B149","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/5965","article-title":"Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction","volume":"21","author":"St John","year":"1999","journal-title":"Nat Genet"},{"issue":"6","key":"B150","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ctrv.2006.05.005","article-title":"Primary bone osteosarcoma in the pediatric age: state of the art","volume":"32","author":"Longhi","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"B151","doi-asserted-by":"publisher","first-page":"627254","DOI":"10.1155\/2012\/627254","article-title":"The genetics of osteosarcoma","volume":"2012","author":"Martin","year":"2012","journal-title":"Sarcoma"},{"issue":"11","key":"B152","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/hmg\/ddp117","article-title":"Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling","volume":"18","author":"Sadikovic","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1","key":"B153","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/039463201302600115","article-title":"The role and clinical significance of YES-associated protein 1 in human osteosarcoma","volume":"26","author":"Zhang","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"B154","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"issue":"3","key":"B155","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3892\/or.2014.3305","article-title":"Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo","volume":"32","author":"Yang","year":"2014","journal-title":"Oncol Rep"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/oncsis.2012.18","article-title":"The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer","volume":"1","author":"Richter","year":"2012","journal-title":"Oncogenesis"},{"issue":"4","key":"B157","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3892\/or.2014.3387","article-title":"RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1\/LATS1 signaling","volume":"32","author":"Zhou","year":"2014","journal-title":"Oncol Rep"},{"issue":"45","key":"B158","doi-asserted-by":"publisher","first-page":"35029","DOI":"10.1074\/jbc.M110.165506","article-title":"Tumor suppressor Ras association domain family 5 (RASSF5\/NORE1) mediates death receptor ligand-induced apoptosis","volume":"285","author":"Park","year":"2010","journal-title":"J Biol Chem"},{"issue":"11","key":"B159","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.cellsig.2014.07.031","article-title":"CD44 acts through RhoA to regulate YAP signaling","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell Signal"},{"issue":"4","key":"B160","doi-asserted-by":"publisher","first-page":"e60329","DOI":"10.1371\/journal.pone.0060329","article-title":"Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID mice","volume":"8","author":"Gvozdenovic","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"B161","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ctrv.2015.03.008","article-title":"Targeted therapies for advanced Ewing sarcoma family of tumors","volume":"41","author":"Jiang","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"B162","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2217\/14796694.1.4.521","article-title":"Ewing\u2019s sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent","volume":"1","author":"Uren","year":"2005","journal-title":"Future Oncol"},{"issue":"17","key":"B163","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1038\/onc.2010.571","article-title":"BMI-1 suppresses contact inhibition and stabilizes YAP in Ewing sarcoma","volume":"30","author":"Hsu","year":"2011","journal-title":"Oncogene"},{"issue":"16","key":"B164","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1158\/0008-5472.CAN-07-6152","article-title":"BMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repression","volume":"68","author":"Douglas","year":"2008","journal-title":"Cancer Res"},{"issue":"9","key":"B165","doi-asserted-by":"publisher","first-page":"893","DOI":"10.4161\/epi.25617","article-title":"RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma","volume":"8","author":"Gharanei","year":"2013","journal-title":"Epigenetics"},{"issue":"6","key":"B166","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/pbc.22115","article-title":"Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma","volume":"53","author":"Avigad","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"27","key":"B167","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1038\/sj.onc.1205446","article-title":"Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines","volume":"21","author":"Harada","year":"2002","journal-title":"Oncogene"},{"key":"B168","doi-asserted-by":"publisher","first-page":"498472","DOI":"10.1155\/2012\/498472","article-title":"DNA methylation and gene expression profiling of ewing sarcoma primary tumors reveal genes that are potential targets of epigenetic inactivation","volume":"2012","author":"Patel","year":"2012","journal-title":"Sarcoma"},{"issue":"7","key":"B169","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.celrep.2015.01.042","article-title":"Epigenome mapping reveals distinct modes of gene regulation and widespread enhancer reprogramming by the oncogenic fusion protein EWS-FLI1","volume":"10","author":"Tomazou","year":"2015","journal-title":"Cell Rep"},{"issue":"3","key":"B170","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.suc.2008.03.008","article-title":"Pediatric soft tissue sarcomas","volume":"88","author":"Loeb","year":"2008","journal-title":"Surg Clin North Am"},{"issue":"24","key":"B171","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1200\/JCO.2005.05.3801","article-title":"Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children\u2019s Oncology Group","volume":"24","author":"Meza","year":"2006","journal-title":"J Clin Oncol"},{"issue":"14","key":"B172","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1200\/JCO.2007.14.7207","article-title":"Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups","volume":"26","author":"Oberlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"B173","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1200\/JCO.2008.21.1268","article-title":"Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children\u2019s oncology group","volume":"28","author":"Davicioni","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"B174","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/2159-8290.CD-13-0639","article-title":"Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors","volume":"4","author":"Shern","year":"2014","journal-title":"Cancer Discov"},{"issue":"40","key":"B175","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/sj.onc.1204599","article-title":"Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma","volume":"20","author":"Barr","year":"2001","journal-title":"Oncogene"},{"issue":"14","key":"B176","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1200\/JCO.2011.38.5591","article-title":"PAX3\/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification","volume":"30","author":"Missiaglia","year":"2012","journal-title":"J Clin Oncol"},{"issue":"13","key":"B177","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1200\/JCO.2009.26.3814","article-title":"Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma","volume":"28","author":"Williamson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"B178","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1172\/JCI67087","article-title":"Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression","volume":"124","author":"Crose","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"B179","doi-asserted-by":"publisher","first-page":"e59622","DOI":"10.1371\/journal.pone.0059622","article-title":"Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy","volume":"8","author":"Judson","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"B180","doi-asserted-by":"publisher","first-page":"e1005075","DOI":"10.1371\/journal.pgen.1005075","article-title":"Clonality and evolutionary history of rhabdomyosarcoma","volume":"11","author":"Chen","year":"2015","journal-title":"PLoS Genet"},{"issue":"6","key":"B181","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/gcc.22050","article-title":"Recurrent NCOA2 gene rearrangements in congenital\/infantile spindle cell rhabdomyosarcoma","volume":"52","author":"Mosquera","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"B182","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.5858\/arpa.2012-0465-RS","article-title":"Spindle cell rhabdomyosarcoma: a brief diagnostic review and differential diagnosis","volume":"137","author":"Carroll","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"B183","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/or.2014.3180","article-title":"Chromosome aberrations and HEY1-NCOA2 fusion gene in a mesenchymal chondrosarcoma","volume":"32","author":"Panagopoulos","year":"2014","journal-title":"Oncol Rep"},{"issue":"18","key":"B184","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1200\/JCO.2005.03.209","article-title":"Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study","volume":"23","author":"Pappo","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"B185","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc1168","article-title":"Mechanisms of sarcoma development","volume":"3","author":"Helman","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"26","key":"B186","doi-asserted-by":"publisher","first-page":"E3402","DOI":"10.1073\/pnas.1420005112","article-title":"Deregulation of the Hippo pathway in soft-tissue sarcoma promotes FOXM1 expression and tumorigenesis","volume":"112","author":"Eisinger-Mathason","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"B187","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/mc.20317","article-title":"Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma","volume":"46","author":"Seidel","year":"2007","journal-title":"Mol Carcinog"},{"issue":"10","key":"B188","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/01.LAB.0000032381.68634.CA","article-title":"Molecular alterations of h-warts\/LATS1 tumor suppressor in human soft tissue sarcoma","volume":"82","author":"Hisaoka","year":"2002","journal-title":"Lab Invest"},{"issue":"3","key":"B189","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ijc.20707","article-title":"Alterations of cancer-related genes in soft tissue sarcomas: hypermethylation of RASSF1A is frequently detected in leiomyosarcoma and associated with poor prognosis in sarcoma","volume":"114","author":"Seidel","year":"2005","journal-title":"Int J Cancer"},{"issue":"2","key":"B190","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1194\/jlr.M032755","article-title":"Vestigial-like 3 is an inhibitor of adipocyte differentiation","volume":"54","author":"Halperin","year":"2013","journal-title":"J Lipid Res"},{"issue":"12","key":"B191","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/gcc.20825","article-title":"YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomas","volume":"49","author":"Helias-Rodzewicz","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"B192","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/path.2513","article-title":"Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions","volume":"217","author":"Hallor","year":"2009","journal-title":"J Pathol"},{"issue":"98","key":"B193","doi-asserted-by":"publisher","first-page":"98ra82","DOI":"10.1126\/scitranslmed.3002409","article-title":"Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma","volume":"3","author":"Tanas","year":"2011","journal-title":"Sci Transl Med"},{"issue":"8","key":"B194","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"B195","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"B196","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1746-1596-9-131","article-title":"Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases","volume":"9","author":"Flucke","year":"2014","journal-title":"Diagn Pathol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1111\/his.12697","article-title":"Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants","author":"Patel","year":"2015","journal-title":"Histopathology"},{"issue":"39","key":"B198","doi-asserted-by":"publisher","first-page":"6541","DOI":"10.1038\/sj.onc.1207858","article-title":"Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin","volume":"23","author":"Robanus-Maandag","year":"2004","journal-title":"Oncogene"},{"issue":"13","key":"B199","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1101\/gad.14.13.1617","article-title":"Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2","volume":"14","author":"Giovannini","year":"2000","journal-title":"Gene Dev"},{"issue":"12","key":"B200","doi-asserted-by":"publisher","first-page":"r137","DOI":"10.1186\/gb-2013-14-12-r137","article-title":"Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas","volume":"14","author":"Renner","year":"2013","journal-title":"Genome Biol"},{"issue":"1","key":"B201","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrd4161","article-title":"The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment","volume":"13","author":"Johnson","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"B202","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2013.08.006","article-title":"Regulation of the Hippo pathway and implications for anticancer drug development","volume":"34","author":"Park","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"B203","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","article-title":"Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization \u2013 verteporfin in photodynamic therapy report 2","volume":"131","author":"Verteporfin in Photodynamic Therapy Study Group","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exer.2014.04.011","article-title":"The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation","volume":"124","author":"Brodowska","year":"2014","journal-title":"Exp Eye Res"},{"issue":"2","key":"B205","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1096\/fj.14-262980","article-title":"Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides","volume":"29","author":"Zhou","year":"2015","journal-title":"FASEB J"},{"issue":"21","key":"B206","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1101\/gad.1978810","article-title":"The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program","volume":"24","author":"Cai","year":"2010","journal-title":"Gene Dev"},{"issue":"4","key":"B207","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nrclinonc.2015.31","article-title":"Targeted therapies: Hippo effector YAP1 inhibition-towards a new therapeutic option to overcome drug resistance","volume":"12","author":"Errico","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"B208","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/ng.3218","article-title":"The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies","volume":"47","author":"Lin","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"B209","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-14-2191","article-title":"The Hippo coactivator YAP1 mediates EGFR overexpression and confers chemo-resistance in esophageal cancer","volume":"21","author":"Song","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"B210","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.109.155630","article-title":"Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and(beta12-beta13)-chimeras (PP1\/PP2A and PP5\/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors","volume":"331","author":"Swingle","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"B211","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1124\/mol.108.053140","article-title":"Targeting protein serine\/threonine phosphatases for drug development","volume":"75","author":"McConnell","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"6","key":"B212","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1021\/jm8005806","article-title":"Toward the development of a potent and selective organoruthenium mammalian sterile 20 kinase inhibitor","volume":"52","author":"Anand","year":"2009","journal-title":"J Med Chem"},{"issue":"6","key":"B213","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1158\/1535-7163.MCT-13-0918","article-title":"Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of Hippo, TGF-beta, and Wnt signaling pathways","volume":"13","author":"Basu","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"B214","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/j.1476-5381.2011.01664.x","article-title":"TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ","volume":"165","author":"Jang","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"7","key":"B215","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.semcdb.2011.09.012","article-title":"14-3-3 proteins as potential therapeutic targets","volume":"22","author":"Zhao","year":"2011","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"B216","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ccr.2014.01.010","article-title":"A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer","volume":"25","author":"Jiao","year":"2014","journal-title":"Cancer Cell"},{"issue":"1","key":"B217","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2012.11.007","article-title":"Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models","volume":"23","author":"Corcoran","year":"2013","journal-title":"Cancer Cell"},{"issue":"11","key":"B218","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1101\/gad.219402.113","article-title":"Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation","volume":"27","author":"Yu","year":"2013","journal-title":"Genes Dev"},{"issue":"2","key":"B219","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/jb\/mvr063","article-title":"A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription","volume":"150","author":"Bao","year":"2011","journal-title":"J Biochem"},{"issue":"8","key":"B220","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.chembiol.2012.07.005","article-title":"Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP","volume":"19","author":"Miller","year":"2012","journal-title":"Chem Biol"},{"issue":"10","key":"B221","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/ijc.21682","article-title":"Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects","volume":"118","author":"Gamble","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"B222","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/cmdc.200600280","article-title":"Alpha-substituted phosphonate analogues of lysophosphatidic acid (LPA) selectively inhibit production and action of LPA","volume":"2","author":"Jiang","year":"2007","journal-title":"ChemMedChem"},{"issue":"19","key":"B223","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1101\/gad.197582.112","article-title":"Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs)","volume":"26","author":"Mo","year":"2012","journal-title":"Genes Dev"},{"issue":"3","key":"B224","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jmb.2011.02.061","article-title":"Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibody","volume":"408","author":"Fleming","year":"2011","journal-title":"J Mol Biol"},{"issue":"8","key":"B225","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/emmm.201200244","article-title":"Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1\/sphingosine 1-phosphate signalling to regulate tumour metastasis","volume":"4","author":"Ponnusamy","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"42","key":"B226","doi-asserted-by":"publisher","first-page":"17717","DOI":"10.1073\/pnas.0906153106","article-title":"The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen","volume":"106","author":"Wojciak","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B227","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1527-3466.2001.tb00066.x","article-title":"Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall","volume":"19","author":"Kishi","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"issue":"12","key":"B228","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1517\/13543776.2014.968127","article-title":"cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases","volume":"24","author":"Martinez","year":"2014","journal-title":"Expert Opin Ther Pat"},{"issue":"17","key":"B229","doi-asserted-by":"publisher","first-page":"14771","DOI":"10.1074\/jbc.M201072200","article-title":"Interaction of the Rho-ADP-ribosylating C3 exoenzyme with RalA","volume":"277","author":"Wilde","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"B230","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/cncr.28657","article-title":"Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone","volume":"120","author":"Doyle","year":"2014","journal-title":"Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T04:37:04Z","timestamp":1653194224000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2015.00190\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":230,"URL":"https:\/\/doi.org\/10.3389\/fonc.2015.00190","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}